Author:
Austin Zamarripa C.,Edwards Shelley R.,Qureshi Hina N.,Yi John N.,Blough Bruce E.,Freeman Kevin B.
Funder
Department of Psychiatry and Human Behavior at the University of Mississippi Medical Center
National Institute on Drug Abuse
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology
Reference32 articles.
1. Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence;Altarifi;Behav. Pharmacol.,2011
2. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents;Altarifi;J. Psychopharmacol.,2017
3. Principles of drug abuse liability assessment in laboratory animals;Ator;Drug Alcohol Depend.,2003
4. Enhanced morphine analgesia in mice lacking beta-arrestin 2;Bohn;Science,1999
5. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence;Bohn;Nature,2000
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献